Capecitabine
Capecitabine is an oral chemotherapy medication known by the original brand name Xeloda. It serves as an antimetabolite agent used in various cancer treatment plans. Capnat provides the available form for specific oncology needs.
Key points
- Classed as a fluoropyrimidine carbamate, it works as a prodrug, becoming active against cancer cells only once the body has absorbed and converted it.
- It accumulates more readily in tumour tissue than in surrounding healthy tissue, giving the treatment its targeted effect on cancer cells.
- It treats colorectal, breast and gastric cancers, usually as one part of a wider treatment plan directed by an oncologist.
What is Capecitabine?
Capecitabine belongs to a class of medications called fluoropyrimidine carbamates. It acts as a prodrug, meaning the body converts the chemical into an active anti-cancer compound after it is absorbed. This targeted approach allows the medication to accumulate more effectively in tumour tissues compared to surrounding healthy cells.
What Capecitabine is used for
Medical providers use this medication to support patients managing specific conditions. These include Colorectal Cancer, Breast Cancer, and Gastric Cancer. It is generally utilised as part of a broader treatment protocol defined by an oncologist.
Capecitabine brands and forms
The original formulation is known as Xeloda, and generic options like Capnat exist. These are commonly available as a film-coated tablet for oral administration. For information on the broader context of these treatments, see Oncology Support.
Safety overview for Capecitabine
What to check before using this medicine
Patients often require baseline assessments of liver, kidney, or heart function before starting this treatment.
Possible reactions and tolerability
Diarrhoea, fatigue, and hand-foot syndrome are documented reactions associated with this chemical class.
Interactions and health factors
Pre-existing health conditions or other medications can influence treatment suitability. Product labelling and verified clinical sources remain the correct references for specific contraindications, interactions and reactions.